mérial

Merial was a global animal health company that operated as a subsidiary of Sanofi. Headquartered in Lyon, France, and Duluth, Georgia, USA, Merial was a significant player in the veterinary pharmaceutical and vaccine market. The company's product portfolio included a wide range of solutions for companion animals, livestock, and poultry.

Merial's offerings spanned various therapeutic areas, addressing needs such as parasite control, disease prevention, and treatment for common ailments. Key product lines included well-known brands for flea and tick prevention in dogs and cats, as well as vaccines for both small and large animals. The company also developed and marketed products aimed at improving the health and productivity of farm animals, contributing to global food security.

The company was founded in 1997 through the merger of the animal health businesses of Merck & Co. and Rhône-Mérieux. This union created a powerful entity with a broad global reach and extensive research and development capabilities. Merial was committed to innovation, investing in scientific research to discover and develop novel solutions for animal health challenges. In 2019, Merial was integrated into Boehringer Ingelheim Animal Health following a strategic asset swap between Sanofi and Boehringer Ingelheim. This integration marked the end of Merial as an independent entity, with its products and operations becoming part of Boehringer Ingelheim's animal health division.